Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

mdm2: a bridge over the two tumour suppressors, p53 and Rb

Oncogene volume 18, pages 7681–7689 (1999)Cite this article

Abstract

The inactivation of the p53 and Rb pathways would account for the majority of human tumours. There are many levels of cross talk between p53 and Rb that have been identified. However, the identification of the mdm2-Rb interaction established a closer link between the two most well studied tumour suppressors, p53 and Rb. Recent studies of the novel trimeric complex Rb-mdm2-p53 provided us with a functional insight of how the two tumour suppressors can act together in regulating p53 induced apoptosis. Beginning with the properties of the Rb-mdm2-p53 trimeric complex, we shall review the propounding evidence suggesting that the apoptotic function of p53 is linked to its transrepression function. The uncoupling of the apoptotic function and transactivation function of p53 will also be discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Amellem Q, Stokke T, Sandvik JA and Pettersen EO. . 1996 Exp. Cell Res. 227: 106–115.

  • Barak Y, Juven T, Haffner R and Oren M. . 1993 EMBO J. 12: 461–468.

  • Bottger A, Bottger V, Sparks A, Liu W-L, Howard SF and Lane DP. . 1997 Curr. Biol. 7: 860–869.

  • Bremner R, Du DC, Connolly-Wilson MJ, Bridge P, Ahmad KF, Mostachfi H, Rushlow D, Dunn JM and Gallie B. . 1997 Am. J. Hum. Genet. 61: 556–570.

  • Buckbinder L, Talbott R, Valesco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N. . 1995 Nature 377: 646–649.

  • Caelles C, Helmberg A and Karin M. . 1994 Nature 370: 220–223.

  • Campanero M and Flemington EK. . 1997 Proc. Natl. Acad. Sci. USA 94: 2221–2226.

  • Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR. . 1991 Cell 65: 1053–1061.

  • Chen X, Ko LJ, Jayaraman L and Prives C. . 1996a Genes Dev. 10: 2438–2451.

  • Chen X, Wu X, Lin J and Levine AJ. . 1996b Mol. Cell. Biol. 16: 2445–2452.

  • Chiou SK, Rao L and White E. . 1994 Mol. Cell. Biol. 14: 2556–2563.

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. . 1993 Nature 362: 849–852.

  • Cordon-Cardo C, Zhang ZF, Dalbagni G, Dorbnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE and Benedict WF. . 1997 Cancer Res. 57: 1217–1221.

  • Crook T, Marston NJ, Sara EA and Vousden KH. . 1994 Cell 79: 817–827.

  • de Oca Luna RM, Wagner DS and Lozano G. . 1995 Nature 378: 203–206.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA. . 1993 Cell 73: 499–511.

  • Dyson N, Howley PM, Munger K and Harlow E. . 1989 Science 243: 934–936.

  • El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parson VE, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Eliyahu D, Michalovitz D, Eliyahu S, Pinashi-Kimhi O and Oren M. . 1989 Proc. Natl. Acad. Sci. USA 86: 8763–8767.

  • Field S and Jang SJ. . 1990 Science 249: 1046–1049.

  • Finlay CA, Hinds PW and Levine AJ. . 1989 Cell 57: 1083–1093.

  • Friedlander P, Haupt Y, Prives C and Oren M. . 1996 Mol. Cell. Biol. 16: 4961–4971.

  • Ginsberg D, Mechta F, Yaniv M and Oren M. . 1991 Proc. Natl. Acad. Sci. USA 88: 9979–9983.

  • Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON and Sawyers CL. . 1995 Oncogene 11: 791–799.

  • Harbour JW. . 1998 Ophthalmology 105: 1442–1447.

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.

  • Hateboer G, Kerkhoven RM, Shvarts A, Bernards R and Beijersbergen RL. . 1996 Genes Dev. 10: 2960–2970.

  • Haupt Y, Barak Y and Oren M. . 1996 EMBO J. 15: 1596–1606.

  • Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296–299.

  • Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. . 1995 Genes Dev. 9: 2170–2183.

  • Hofmann F, Martelli F, Livingston DM and Wang Z. . 1996 Genes Dev. 10: 2949–2959.

  • Hollstein M, Sidransky D, Vogelstein B and Harris C. . 1991 Science 253: 49–53.

  • Holmberg C, Helin K, Sehested M and Karlstrom O. . 1998 Oncogene 17: 143–155.

  • Honda R and Yasuda H. . 1999 EMBO J. 18: 22–27.

  • Hsieh J-K, Chan FSG, O'Connor DJ, Mittnacht S, Zhong S and Lu X. . 1999 Mol. Cell 3: 181–193.

  • Hsieh J-K, Fredersdorf S, Kauzarides T, Martin K and Lu X. . 1997 Genes Dev. 11: 1840–1852.

  • Jones SN, Roe AE, Donehower LA and Bradley A. . 1995 Nature 378: 206–208.

  • Knudson MK, Tung K, Tourtellotte G, Brown GAJ and Korsmmer SJ. . 1995 Science 270: 96–98.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Krtolica A, Krucher N and Ludlow J. . 1998 Oncogene 17: 2295–2304.

  • Kubbutat MH, Jones SN and Vousden KH. . 1997 Nature 387: 299–303.

  • Kubbutat MHG and Vousden KH. . 1997 Mol. Cell. Biol. 17: 460–468.

  • Lane DP and Crawford LV. . 1979 Nature 278: 261–263.

  • Lee W-H, Bookstein R, Hong F, Yong L-J, Shew J-Y and Lee EY-H. . 1987 Science 235: 1394–1399.

  • Levine AJ. . 1990 BioEssays 12: 62–66.

  • Levine AJ and Momand J. . 1990 Biochim. Biophys. Acta 1032: 119–136.

  • Levine AJ, Momand J and Finlay CA. . 1991 Nature 351: 453–456.

  • Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL, Sala A, Travali S, Appella E and Mercer WE. . 1994 Proc. Natl. Acad. Sci. USA 91: 10079–10083.

  • Linzer DIH and Levine AJ. . 1979 Cell 17: 43–52.

  • Lohmann DR, Brandt B, Hopping W, Passarge E and Horsthemke B. . 1996 Am. J. Hum. Genet. 58: 940–949.

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. . 1993 Nature 362: 847–852.

  • Lu X, Burbidge SA, Griffin S and Smith HM. . 1996 Oncogene 13: 413–418.

  • Ludwig RT, Bates S and Vousden KH. . 1996 Mol. Cell. Biol. 16: 4952–4960.

  • Mack DH, Vartikar J, Pipas JM and Laimins LA. . 1993 Nature 363: 281–283.

  • Macleod KF, Hu Y and Jacks T. . 1996 EMBO J. 15: 6178–6188.

  • Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CM, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA and Friend SH. . 1990 Science 250: 1233–1238.

  • Marshall CJ. . 1991 Cell 64: 313–326.

  • Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB and Kouzarides T. . 1995 Nature 375: 691–694.

  • Matsumoto R, Tada M, Nozaki M, Zhang C-L, Sawamura Y and Abe H. . 1998 Cancer Res. 58: 609–613.

  • Mittnacht S. . 1998 Curr. Opin. Genet. Dev. 8: 21–27.

  • Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebernmann DA, Hoffman B and Reed JC. . 1994 Oncogene 9: 1799–1805.

  • Miyashita T and Reed JC. . 1995 Cell 80: p293–299.

  • Momand J, Zambetti GP, Oslon DC, George D and Levine AJ. . 1992 Cell 69: 1237–1245.

  • Morgenbesser SD, Williams BO, Jacks T and Depino RA. . 1994 Nature 371: 72–74.

  • Murphy M, Hinman A and Levine AJ. . 1996 Genes Dev. 10: 2971–2980.

  • Nevins JR. . 1992 Science 258: 424–429.

  • Oliner JD, Pietenpol JA, Thiagalingan S, Gyruis J, Kinzler KW and Vogelstein B. . 1993 Nature 362: 857–860.

  • Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L and Van Dyke T. . 1998 Mol. Cell 2: 283–292.

  • Phillips AC, Bates S, Ryan KM, Helin K and Vousden KH. . 1997 Genes Dev. 11: 1853–1863.

  • Picksley SM, Vojtesek B, Sparks A and Lane DP. . 1994 Oncogene 9: 2523–2529.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Qin XQ, Livingston DM, Kaelin WGJ and Adams PD. . 1994 Proc. Natl. Acad. Sci. USA 91: 10918–10922.

  • Raycroft L, Wu HY and Lozano G. . 1990 Science 249: 1049–1051.

  • Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. . 1996 EMBO J. 15: 827–838.

  • Ryan KM and Vousden KH. . 1998 Mol. Cell. Biol. 18: 3692–3698.

  • Sabbatini P, Chiou S-K, Rao L and White E. . 1995a Mol. Cell. Biol. 15: 1060–1070.

  • Sabbatini P, Han J, Chiou S-K, Nicholson DW and White E. . 1997 Cell Growth Differ. 8: 643–653.

  • Sabbatini P, Lin J, Levine AJ and White E. . 1995b Genes Dev. 9: 2184–2192.

  • Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Neinmann R, Levine AJ and Shenk T. . 1992 Proc. Natl. Acad. Sci. USA 89: 12028–12032.

  • Shan B and Lee W-H. . 1994 Mol. Cell. Biol. 14: 8166–8173.

  • Shaulian E, Haviv I, Shaul Y and Oren M. . 1995 Oncogene 10: 671–680.

  • Shen Y and Shenk T. . 1994 Proc. Natl. Acad. Sci. USA 91: 8940–8944.

  • Sherr CJ. . 1996 Science 274: 1672–1677.

  • Shieh S-Y, Ikeda M, Taya Y and Prives C. . 1997 Cell 91: 325–334.

  • Sigalas I, Calver AH, Anderson JJ, Neal DE and Lunec J. . 1996 Nature Med. 2: 912–917.

  • Stott F, Bates S, James M, McConne IB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden K and Peters G. . 1998 EMBO J. 17: 5001–5014.

  • Subler MA, Martin DW and Deb S. . 1992 J. Virol. 66: 4757–4762.

  • Subler MA, Martin DW and Deb S. . 1994 Oncogene 9: 1351–1359.

  • Thut C, Goodrich JA and Tjian R. . 1997 Genes Dev. 11: 1974–1986.

  • Thut CJ, Chen JL, Klemm R and Tjian R. . 1995 Science 267: 100–104.

  • Tsai K, Hu Y, Macleod K, Crowley D, Yamasaki L and Jacks T. . 1998 Mol. Cell 2: 293–304.

  • Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L and Debussche L. . 1998 EMBO J. 17: 4668–4679.

  • Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki M, Kotoura Y and Yamamuro T. . 1994 Cancer Res. 54: 3042–3048.

  • Walker KK and Levine AJ. . 1996 Proc. Natl. Acad. Sci. USA 93: 15335–15340.

  • Weinberg RA. . 1995 Cell 81: 323–330.

  • Welch PJ and Wang JYJ. . 1993 Cell 75: 779–790.

  • Welch PJ and Wang JYJ. . 1995 Genes Dev. 9: 31–46.

  • Wu X and Levine AJ. . 1994 Proc. Natl. Acad. Sci. USA 91: 3602–3606.

  • Xiao ZX, Chen J, Levine A, Modjtahedl N, Xing J, Sellers WR and Livingston DM. . 1995 Nature 375: 694–697.

  • Xu H-J, Cagle PT, Hu S-X, Li J and Benedict WF. . 1995 Clin. Cancer Res. 2: 1169–1176.

  • Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL and Benedict WF. . 1994 J. Natl. Cancer Inst. 86: 695–699.

  • Yuan Z-M, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R and Kufe D. . 1997 Proc. Natl. Acad. Sci. USA 94: 1437–1440.

  • Yuan Z-M, Huang Y, Whang Y, Sayers C, Weichselbaum R, Kharbanda S and Kufe D. . 1996 Nature 382: 272–274.

  • Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.

Download references

Author information

Authors and Affiliations

  1. Ludwig Institute for Cancer Research, Imperial College School of Medicine, St. Mary's campus, Norfolk Place, London, W2 1PG, UK

    Damian BS Yap, Jung-Kuang Hsieh, Florence SG Chan & Xin Lu

Authors
  1. Damian BS Yap
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jung-Kuang Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Florence SG Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yap, D., Hsieh, JK., Chan, F. et al. mdm2: a bridge over the two tumour suppressors, p53 and Rb. Oncogene 18, 7681–7689 (1999). https://doi.org/10.1038/sj.onc.1202954

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202954

Keywords

This article is cited by

Search

Advanced search

Quick links